An estimated 70 percent of all antibiotics used in the United States are regularly added to the feed of livestock and poultry that are not sick. Bacteria that are constantly exposed to antibiotics develop antibiotic resistance. This means that when humans get sick from resistant bacteria, the antibiotics prescribed by doctors don't work. Antibiotic resistance is becoming increasingly common, and scientists agree that the overuse of antibiotics in CAFOs (confined animal feeding operations) plays a big role. Today, new antibiotic-resistant diseases are being linked to CAFO practices, including methicillin-resistant Staphylococcus aureus (MRSA), a disease responsible for over 18,000 deaths each year in the United States. Why isn’t the Food and Drug Administration (FDA) putting an end to the use of these drugs in CAFOs for animals that are not even sick? Even if FDA had the will to act, agency resources are tied up elsewhere. Applications by drug companies for new animal drugs are reviewed by the FDA in exchange for fees from industry. This faulty “user fee” arrangement forces the FDA to be financially dependent on the very industry it is tasked with regulating, dictates the agency’s priorities, and forces the agency to adhere to strict deadlines for new drug approvals. As a consequence, other priorities, such as reviewing the effect of already approved antibiotics on human and animal health, are virtually ignored. More... |